SEC 13F Intelligence

Cheyne Capital Management (UK) LLP / ACRS

Cheyne Capital Management (UK) LLP’s Aclaris Therapeutics Inc Position

Does Cheyne Capital Management (UK) LLP own Aclaris Therapeutics Inc (ACRS)? Not currently — the last reported position was 51.0K shares worth $802,683 in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$802,683
Q4 2022
Shares
51.0K
% of Portfolio
+1.40%
Quarters Held
1
position exited

Position History ACRS

Reported value by quarter
Q4 ’22: $802,683Q4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202251.0K$802,683+1.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of ACRS.